Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE)

Galderma R&D301 enrolled

Overview

The aim of the study is to evaluate the level of satisfaction among patients to whom Mirvaso® / Onreltea TM (trade mark) is prescribed.

Study Type

OBSERVATIONAL

Enrollment

301

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients to whom the physician has already decided to prescribe Mirvaso® /OnrelteaTM according to package insert

Investigator site 1

Hamilton, Canada

Satisfaction Among Patients to Whom Mirvaso®/OnrelteaTM is Prescribed Question

Time frame: Week 4

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.